Skip to content

Clinical trials

Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Clear all

1,000 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200111
200211
200328
200436
200538
200651
200731
200842
200931
201042
201141
201235
201338
201442
201548
201640
201738
201850
201953
202040
202139
202234
202323
202437
202538
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed602
Unknown status192
Recruiting60
Terminated56
Not yet recruiting39
Active, not recruiting22
Withdrawn21
Enrolling by invitation5
No longer available2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline140
Sanofi Pasteur, a Sanofi Company28
Gilead Sciences22
National Taiwan University Hospital19
Merck Sharp & Dohme LLC17
Third Affiliated Hospital, Sun Yat-Sen University17
National Institute of Allergy and Infectious Diseases (NIAID)15
Dynavax Technologies Corporation13
Bristol-Myers Squibb12
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B1,000
Hepatitis B, Chronic162
Tetanus105
Hepatitis C104
Diphtheria101
Haemophilus Infections82
Whooping Cough72
Poliomyelitis68
HIV Infections62
Carcinoma, Hepatocellular59

Trials

Showing 51 to 75 of 1,000. Each trial links to its page on Pharma Observatory.

900 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.